Jane Street
ARTL icon

Jane Street’s Artelo Biosciences ARTL Stock Holding History

Jane Street’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.1K Buy
+13,079
New +$61.9K ﹤0.01% 10659
2021
Q2 		– Sell
-78
Closed -$34K – 9736
2021
Q1 		$34K Buy
+78
New +$33.3K ﹤0.01% 8907

Other funds holding ARTL

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jane Street's ARTL Position: Q1 2026 in Review

Jane Street opened a new position in Artelo Biosciences (ARTL) in Q1 2026: 13,079 shares worth $99.1K. The stake represents ﹤0.01% of the portfolio and ranks #10659 among its holdings. This is a return to the name: Jane Street previously reported a position in ARTL as recently as Q1 2021.

Jane Street first reported a position in ARTL in Q1 2021 and has held it in 2 quarters since. 11 funds tracked by Wall St. Rank hold ARTL as of Q1 2026.

  • Jane Street held 13,079 shares of Artelo Biosciences worth $99.1K as of Q1 2026.
  • Artelo Biosciences was a new Jane Street position in Q1 2026.
  • Artelo Biosciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10659 holding.
  • Jane Street first reported a position in Artelo Biosciences in Q1 2021 and has held it in 2 quarters since.
  • 11 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.